fbpx Skip to main content

Member's Profile

Amydis Diagnostics

10210 Campus Point Dr Ste 150
San Diego,   California
United States
Medical Device & Diagnostic
Membership Info
Membership Type: Industry
Membership Since: 2017
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Amydis Diagnostics
Medical Device & Diagnostic Company
Amydis, Inc., founded in 2013, is a privately-held company discovering novel small molecule drugs to allow direct visualization of CNS molecular pathology through the retina to detect, monitor, and screen diseases that involve the presence of amyloid proteins. Our mission is to develop a simple, non-invasive eye test that is faster, more accessible, and more affordable than current tests. Amydis has a platform of novel compounds that fluoresce when bound to amyloid-related proteins, thus enabling visual diagnosis of such diseases. Amydis pharmacologic compounds will enable eye care specialists the ability to refer patients at risk early to neurologists, addressing a current unmet need and gap in our healthcare system where patients see a neurologist when the disease is advanced. Neurologist will have access to the first affordable and accessible tool to quantifiably monitor disease progression.
Related News
No related news posted by this Member